1 suspended. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Suspended 1 |
Follow deCODE genetics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina veliflapon (DG-031) - Acute Coronary Syndrome | Phase 3 | Suspended | deCODE genetics | 3450 | 2006-05-01 | 2006-11-29 |
Acute Coronary Syndrome (1) · Angina, Unstable (1) · Coronary Artery Disease (1) · Coronary Thrombosis (1) · Myocardial Infarction (1)
2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid (1)
United States (1)